| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |